Corporate dividend adjustments for Pfizer Inc. (NYSE: PFE) depend on quarterly free cash flow generation, patent expiration impacts, and post-pandemic product revenue stabilization. Management evaluates capital return programs annually based on ongoing financial performance and capital allocation priorities.